Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats. Yang J-S, Xu L-Y, Xiao B-G, Hedlund G, Link H J Neuroimmunol. 2004 Nov; 156(1-2):3-9. PMID: 15465591. Abstract CommentRecommendBookmarkWatch